Home » Emerging Companies

Letters, Testimony & Comments

2012 Special 301 Report: Biotech's International IP Issues
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
February 14 2012
Biotech Leader Provides Testimony at Congressional Hearing on SBIR/STTR Renewal
April 7, 2011
Hearing Testimony Scott Koenig, M.D., PH.D. Before the House of Representatives Committee on Small Business Good morning Chairman...
April 7 2011
Technology Transfer: BIO Comments to Office of Science and Technology Policy on Commercialization of University Research
May 25, 2010
The Biotechnology industry Organization appreciates the opportunity to respond to the Request for Information issued by the Office of...
May 25 2010
GAO Report to Congress: Information on the Government’s Right to Assert Ownership Control over Federally Funded Inventions
July 1 2009
BIO Statement to the Secretary's Advisory Committee on Genetics, Health & Society
May 15, 2009
May 15 2009
BIO's Statement on the Bayh-Dole Act
August 27, 2007
The Biotechnology Industry Organization (BIO) appreciates this opportunity tp provide the perspective of its members on the Bayh-Dole Act...
August 27 2007
Letter opposing use of Bayh-Dole march-in powers
May 24, 2004
May 24 2004
Statement Before the NIH Blue Ribbon Panel on Conflict of Interest Policies
April 16, 2004
April 16 2004
Phyllis Gardner Testimony
July 10, 2003
Chairman Bilirakis and Members of the Committee, I am pleased to testify before you today regarding technology transfer issues as they...
July 10 2003
BIO letter to the editor of the Washington Post clarifying the Bayh-Dole Act
March 29, 2002
March 29 2002
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH)
National Institutes of Health: An International Perspective NIH Mission: To uncover new knowledge that will lead to improved public...

Letters, Testimony & Comments

2012 Special 301 Report: Biotech's International IP Issues
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
Biotech Leader Provides Testimony at Congressional Hearing on SBIR/STTR Renewal
April 7 2011
Hearing Testimony Scott Koenig, M.D., PH.D. Before the House of Representatives Committee on Small Business Good morning Chairman...
Technology Transfer: BIO Comments to Office of Science and Technology Policy on Commercialization of University Research
May 25 2010
The Biotechnology industry Organization appreciates the opportunity to respond to the Request for Information issued by the Office of...
GAO Report to Congress: Information on the Government’s Right to Assert Ownership Control over Federally Funded Inventions
July 1 2009
BIO Statement to the Secretary's Advisory Committee on Genetics, Health & Society
May 15 2009
More Letters, Testimony & Comments →

Press Releases

BIO Study Quantifies Economic Contribution of University & Non-Profit Inventions
June 21 2012
Washington, D.C. (June 21, 2012) – The Biotechnology Industry Organization (BIO) released a report on the...
Biotech Leader Provides Testimony at Congressional Hearing on SBIR/STTR Renewal
April 7 2011
WASHINGTON, D.C. (Thursday, April 07, 2011) - Today, the House Subcommittee on Healthcare and Technology will hold a...
Senate Small Business Committee Reinstates Limited SBIR Grant Eligibility for Firms Majority-Backed by Venture Capital
July 30 2008
WASHINGTON, D.C. (Wednesday, July 30, 2008) - Small businesses that are majority-backed by venture capital, many...
Milken Institute Study Confirms Vital Role of Technology Transfer in Biotechnology Globally, Says BIO
September 20 2006
WASHINGTON, D.C. (September 20, 2006) –The Milken Institute study released today entitled “Mind-to-Market...
Technology Transfer Forum at BIO 2002 in Toronto
May 30 2002
 WASHINGTON, D.C. (May 30, 2002) – The Biotechnology Industry Organization’s (BIO) annual meeting,...